Volume 14, Issue 3, Pages (March 2017)

Slides:

Advertisements

Similar presentations

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Advertisements

Volume 12, Issue 7, Pages (July 2015)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

Volume 11, Issue 2, Pages (February 2014)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device Michele Murphy, MD, Timothy.

Volume 14, Issue 10, Pages (October 2017)

Volume 14, Issue 6, Pages (June 2017)

Volume 15, Issue 6, Pages (June 2018)

Volume 11, Issue 8, Pages (August 2014)

Volume 13, Issue 1, Pages (January 2016)

Volume 7, Issue 10, Pages (October 2010)

Volume 13, Issue 12, Pages (December 2016)

Volume 5, Issue 4, Pages (April 2008)

Volume 11, Issue 1, Pages (January 2014)

Volume 14, Issue 9, Pages (September 2017)

Left atrial appendage closure: A new technique for clinical practice

Volume 9, Issue 1, Pages (January 2012)

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 6, Issue 10, Pages (October 2009)

Volume 14, Issue 6, Pages (June 2017)

Gaurav A. Upadhyay, MD, Jonathan S. Steinberg, MD Heart Rhythm

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Volume 10, Issue 1, Pages (January 2013)

Volume 6, Issue 12, Pages (December 2009)

Volume 13, Issue 7, Pages (July 2016)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device Michele Murphy, MD, Timothy.

Volume 11, Issue 2, Pages (February 2014)

Volume 8, Issue 12, Pages (December 2011)

Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation Brian J. Cross, MD, Mark S. Link, MD, FHRS

Ethnic and racial disparities in cardiac resynchronization therapy

Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference John Wight, BS,

Volume 14, Issue 12, Pages (December 2017)

Volume 15, Issue 1, Pages (January 2018)

Volume 7, Issue 11, (November 2010)

Inappropriate defibrillator shock during gynecologic electrosurgery

Anne Barnett, PA-C, Lee Eckhardt, MD, FHRS, Miguel A. Leal, MD, FHRS

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient Isla McClelland, MD,

Volume 5, Issue 7, Pages (July 2008)

Recurrent idiopathic polymorphic ventricular tachycardia/ventricular fibrillation successfully treated by cardiac sympathetic denervation Faisal Matto,

Volume 9, Issue 1, Pages (January 2012)

Volume 7, Issue 7, Pages (July 2010)

T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator Muhammad R. Afzal, MD, Auroa Badin, MD,

Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation Kasper Aalbæk Kjærgaard,

Volume 14, Issue 12, Pages (December 2017)

Volume 12, Issue 10, Pages (October 2015)

Volume 16, Issue 1, Pages 3-9 (January 2019)

Volume 11, Issue 1, Pages (January 2014)

Volume 7, Issue 3, Pages (March 2010)

Michael R. Gold, MD, PhD, FHRS Heart Rhythm

Volume 15, Issue 1, Pages (January 2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

Volume 11, Issue 3, Pages (March 2014)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator Sing-Chien Yap, MD, PhD, Rohit E. Bhagwandien,

Volume 8, Issue 3, Pages (March 2011)

Volume 6, Issue 2, Pages (February 2009)

Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators Thor Tejada, MD, Faisal.

Volume 10, Issue 9, Pages (September 2013)

Impact of generator replacement on the risk of Fidelis lead fracture

Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination–Implantable.

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Volume 7, Issue 8, Pages (August 2010)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T- wave oversensing in hyperkalemia leading to ventricular fibrillation

Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED): Clinical characteristics and perioperative results

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks Omid Kiamanesh, MD, Jacob M. Larsen, MD, PhD,

Volume 16, Issue 7, Pages (July 2019)

Volume 16, Issue 6, Pages (June 2019)

Volume 14, Issue 6, Pages (June 2017)

Presentation transcript:

Volume 14, Issue 3, Pages 367-375 (March 2017) Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication Lucas V. Boersma, MD, PhD, Craig S. Barr, MD, Martin C. Burke, DO, Angel R. Leon, MD, Dominic A. Theuns, PhD, John M. Herre, MD, Raul Weiss, MD, FACS, FHRS, Mark S. Kremers, MD, FHRS, Petr Neuzil, MD, PhD, Michael P. Husby, MS, FHRS, Nathan Carter, MS, Timothy M. Stivland, BS, MBA, Michael R. Gold, MD, PhD Heart Rhythm Volume 14, Issue 3, Pages 367-375 (March 2017) DOI: 10.1016/j.hrthm.2016.11.025 Copyright © 2016 The Authors Terms and Conditions

Figure 1 A: Differences in clinical etiology of secondary prevention and primary prevention patients. B: Differences in clinical etiology of primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%) and with an ejection fraction >35% (PP EF ≥35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions

Figure 2 A: Kaplan-Meier curves demonstrating freedom from device- and procedure-related complications between primary and secondary prevention subcutaneous implantable defibrillator patients. B: Kaplan-Meier curves demonstrating freedom from device- and procedure-related complications between primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%) and with an ejection fraction >35% (PP EF >35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions

Figure 3 A: Kaplan-Meier curves demonstrating freedom from mortality between primary and secondary prevention subcutaneous implantable defibrillator patients. B: Kaplan-Meier curves demonstrating freedom from mortality between primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%) and with an ejection fraction >35% (PP EF >35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions

Figure 4 A: Kaplan-Meier curves demonstrating freedom from appropriate shock therapy between primary and secondary prevention subcutaneous implantable defibrillator patients. B: Kaplan-Meier curves demonstrating freedom from appropriate shock between primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%) and with an ejection fraction >35% (PP EF >35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions

Figure 5 Incidence of patients experiencing treated ventricular tachycardia/ventricular fibrillation (VT/VF) episodes, self-terminating VT/VF episodes, or both types of episodes in secondary prevention patients, primary prevention patients, primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%), and primary prevention patients with an ejection fraction >35% (PP EF >35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions

Figure 6 A: Kaplan-Meier curves demonstrating freedom from inappropriate shocks between secondary and primary prevention subcutaneous implantable defibrillator patients. B: Kaplan-Meier curves demonstrating freedom from inappropriate shocks between primary prevention patients with an ejection fraction ≤35% (PP EF ≤35%) and with an ejection fraction >35% (PP EF >35%). Heart Rhythm 2017 14, 367-375DOI: (10.1016/j.hrthm.2016.11.025) Copyright © 2016 The Authors Terms and Conditions